TrialBone marrow transplantation2007

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.

D A Pollyea et al.PubMed ↗Publisher ↗

No numbers read from the abstract.